NASDAQ:ASBP | Cash Flow Statement | Aspire Biopharma Holdings, Inc.

Complete source-backed cash-flow history.

Available history
2021-06-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$1.27M
2026-03-31-$3.22M-$3.04M$7.89M
2025-12-31-$4.71M-$927,841.00-$16,526.00
2025-09-30-$1.85M
2025-06-30-$1.98M
2025-03-31-$15.94M-$1.75M$3.09M
2024-12-31-$765,710.00$479,569.00$0.00$0.00-$492,477.00
2024-09-30-$216,269.00
2024-06-30-$96,923.00
2024-03-31-$230,970.00-$192,971.00$229,084.00
2023-12-31-$150,912.00-$156,128.00$0.00$0.00$155,848.00
2023-09-30-$69,258.00
2023-06-30$1.81M
2023-03-31$2.87M-$182,107.00
2022-12-31$2.23M-$35,870.00$0.00$0.00
2022-09-30$1.08M
2022-06-30$120,693.00
2022-03-31-$87,826.00-$1.29M-$294.69M$296.59M
2021-09-30-$15,310.00
2021-06-30-$2,383.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$24.48M-$4.92M$5.92M
2024-12-31-$1.31M-$265,186.00$13.78M$13.78M$257,645.00
2023-12-31$4.46M-$653,107.00$284.92M$284.92M-$284.76M
2022-12-31$3.34M-$1.41M-$294.69M$296.59M